前药物光激活:癌症治疗的有希望的策略
Lingkai Tang1, Yafei Luo2, Wenqin Luo1
1Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, School of Pharmacy, Chengdu University, Chengdu, China.
Current protein & peptide science
|June 26, 2024
概括
(IV) 前药通过增强选择性和克服耐药性,比 (II) 药物提供更好的癌症治疗. 本综述详细介绍了改造策略和光还原机制,用于开发先进的Pt(IV) 前药物.
科学领域:
- 药用化学 医学化学
- 在瘤学瘤学.
- 材料科学 材料科学 材料科学
背景情况:
- (II) 药物 (cisplatin,carboplatin,oxaliplatin) 在临床上是成功的,但面临诸如非特异性激活和耐药性等挑战.
- (IV) 化合物比Pt(II) 药物具有优势,包括改善的药理动力学,选择性和替代性细胞毒性机制.
- 在瘤部位,Pt(IV) 前药可可控地转化为活性Pt(II) 剂,提供克服抗药性的策略.
研究的目的:
- 审查Pt(IV) 前药物修改策略.
- 总结一下光敏剂对Pt (IV) 前药物激活的发展情况.
- 讨论Pt(IV) 前药物的光减光机制和设计策略.
主要方法:
- 关于Pt(IV) 前药物修改策略的文献综述.
- 在Pt(IV) 前药开发中使用的外部和内部光敏剂的汇编.
- 对三种代表性的光还原机制和相关的前药物设计进行分析.
主要成果:
- 可以设计具有增强性质和替代机制的前药物来克服Pt (II) 药物限制.
- 光敏剂在Pt(IV) 前药的受控激活中起着关键作用.
- 了解光还原机制对于合理的Pt(IV) 前药物设计至关重要.
结论:
- 在癌症治疗中,Pt(IV) 前药是一种有希望的进步,提供更好的疗效和减少副作用.
- 战略性修改和激活方法对于最大限度地发挥Pt(IV) 前药的治疗潜力至关重要.
- 这一综述为未来新型Pt(IV) 抗癌剂的分子设计提供了基础.
相关概念视频
Tumor Immunotherapy
510
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
510
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Vaccines
351
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
351


